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Background: Our aim was to investigate the association between respiratory symptoms
and mortality from ischaemic heart disease (IHD) and stroke in a population during 30 years
follow-up.
Methods: In 1972, 19 998 persons aged 15–70 years, living in Oslo, were selected for a
respiratory survey (response 89%). Respiratory symptoms were divided into four groups and
given a score. The association between respiratory symptoms and mortality from IHD and
stroke were investigated separately for men and women, with adjustment for age,
occupational exposure to air pollution and smoking habits.
Results: IHD accounted for 1572 and stroke for 653 of all deaths. The adjusted hazard
ratio (HR) for mortality from IHD in men varied from 1.3 (95% confidence interval, 1.1–1.5)
to 3.0 (2.3–3.8) and in women from 1.2 (1.0–1.5) to 1.9 (1.4–2.5) for cough symptoms and
severe dyspnoea, respectively. Symptom score predicted death from IHD, in a
dose–response manner. The HR for mortality from stroke varied from 1.0 to 2.3 in men
and from 1.1 to 1.5 in women for the symptom groups, but was significant only among men
reporting severe dyspnoea and among women reporting moderate dyspnoea. For all
respiratory symptoms, the excess risk for cardiovascular mortality decreased during
follow-up, but IHD-mortality was still significantly increased the last decade.
Conclusion: We found a significant, positive association between respiratory symptoms
and 30-year mortality from IHD. The positive association was weaker between respiratory
symptoms and long-term mortality from stroke.
& 2007 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Respiratory symptoms are often markers of pathological
changes in the lungs and airways, but can also be markers of
disease in the heart, thorax wall and organs outside the
thorax. Airway obstruction is associated with increased
levels of systemic inflammatory markers like C-reactive
protein and fibrinogen in the blood.1,2 Sin and Man
postulated that persistent pulmonary inflammation pro-
motes release of pro-inflammatory mediators and cytokines
into the circulation and that the mediators stimulate
production and release of acute-phase proteins and inflam-
matory cells, leading to a state of low-grade systemic
inflammation.3 The systemic inflammation, in turn, may
affect blood vessels, in particular promoting atherosclerotic
plaque instability and rupture, leading to acute cardiovas-
cular and cerebrovascular events.
Additionally, even relatively small reductions in lung
function increases the risks for cardiac arrhythmia, coronary
events and cardiovascular mortality by twofold, indepen-
dently of the smoking habit.4,5 Moreover, experimental
studies have further indicated that brief periods of cerebral
hypoxia trigger an inflammatory response in the brain,
characterized in part by neutrophil recruitment and
infiltration into brain parenchyma, and this inflammatory
response contributes to secondary brain injury.6,7
In two previous studies, we found a consistent, positive
association between respiratory symptoms reported and all-
cause-mortality as well as mortality from obstructive lung
diseases.8,9 As circulatory diseases account for 47% of all
cause mortality for the period 1973–2002 in Norway,10 we
decided to extend the analyses to investigate the long-term
relation between respiratory symptoms and mortality due to
cardiovascular disease. We therefore investigated the
association between self-reported respiratory symptoms
and mortality from ischaemic heart disease (IHD) and stroke
over a 30-year period in a large population-based sample.
Methods
Study population, questionnaire and variables used
in the analysis
The respiratory survey was conducted in Oslo, Norway, in
1972 in a population described in detail previously.8,11
Briefly, the population comprised a sample of 19 998 persons
aged 15–70 years living in Oslo, who received a postal
respiratory questionnaire. Informed consent was in 1972
given by answering and returning the questionnaire.
The questionnaire used was a modification of that
published by the British Medical Research Council’s Commit-
tee on Research into Chronic Bronchitis in 1966 and included
11 questions on respiratory symptoms, which were pooled
into four symptom groups (see Appendix A). Persons who
answered ‘‘Yes’’ to one of questions 8, 9, 10 or 11 were
considered to have cough symptoms. Similarly, persons who
answered ‘Yes’ to one of questions 12, 17 or 18 were
considered to have asthma-like symptoms. Those who
answered ‘Yes’ to question 13 or 14 but not question 15 or
16 were considered to have moderate dyspnoea, whereas
those who answered ‘Yes’ to question 15 or 16 wereconsidered to have severe dyspnoea. One or more affirma-
tive answer to a single question was enough to be included in
one symptom group. Thus, subjects who reported several
respiratory symptoms could be classified in more than one
symptom group. A symptom score ranging from 0 to 11 was
defined as the sum of affirmative answers to 11 equally
weighted respiratory symptom questions. The scores were
then arbitrary grouped as 0 (no respiratory symptoms), 1–3,
4–6 and X7 respiratory symptoms.
Smoking habits were divided into five groups on the basis
of the responses to the initial questionnaire: never smokers
(persons who had not smoked daily for more than 1 year),
former smokers (people who had smoked daily for more than
1 year and had stopped smoking for X1 year) and current
smokers (persons who had smoked daily for more than 1
year, and were still smoking or had stopped less than 12
months prior the study). Current smokers were separated
into those who smoked o10, 10–19 and X20 g of tobacco
per day.
Regarding occupational exposure to air pollution, the
respondents were divided in two groups according to a
‘‘yes’’- or ‘‘no’’-answer to the question: ‘‘Have you been
exposed to particles, gases or damp at your working place?’’
The questionnaire also included four questions whether
they had a physician-diagnosed heart disease (angina
pectoris, myocardial infarction, heart failure and other
heart diseases).
Follow-up
Follow-up began on 1 January 1973, at which time 17 678
respondents (8147 men and 9531 women; response 89%)
were alive and living in Norway. They were followed-up until
the date of death or emigration or until 31 December 2002,
whichever occurred first. All residents of Norway have a
unique national registration number that allows complete
follow-up until death or emigration. By 31 December 2002,
the population had been followed-up for 30 years, con-
tributing a total of 489 218 person–years. The characteristics
of the respondents at start of follow-up are given in Table 1.
Notifications of death and causes of death were obtained
from Statistics Norway, with permissions granted by the Data
Inspectorate and the Norwegian Directorate of Health and
Social Services, and the Regional Committee for Medical
Research Ethics. Statistics Norway used the 8th, 9th and
10th revision of the International Classification of Diseases
(ICD)12 during the period 1973–2002. The analyses were
based on mortality from IHD (ICD10 I20–I25) and cerebro-
vascular disease (stroke) (ICD10 I60–I69), given as the
underlying cause of death.
Statistical methods
First, we calculated the crude mortality rate, as the number
of deaths per 100 000 person-years in the study. Then the
association between respiratory symptom group and mor-
tality was expressed as a hazard ratio (HR), estimated from
a Cox proportional hazard regression model.13 As mortality
was more strongly associated with age than time in the study
or calendar time, age was used as the underlying time
scale.14,15 The mortality associated with each symptom
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Table 1 Characteristics at 1 January 1973 and crude mortality rate per 100 000 person–years (MR) from ischaemic heart
disease (IHD) and stroke among respondents during follow-up, Oslo, Norway, 1973–2002, by sex, age group, respiratory
symptoms, occupational exposure and smoking habits.
Characteristic Total at 1 January 1973
(n ¼ 17 678)
Deaths from IHD
(n ¼ 1572)
Deaths from stroke
(n ¼ 653)
n % n MR n MR
Sex
Men 8147 46 921 469 263 134
Women 9531 54 651 266 390 159
Age group (years) at baseline
15–29 5548 31 25 16 6 4
30–44 3736 21 99 95 22 21
45–59 5098 29 699 579 227 188
60–70 3296 19 749 1364 398 725
Respiratory symptomsa
None 8696 49 638 238 301 134
Groups
Cough symptoms 5732 32 618 455 227 147
Asthma-like symptoms 6092 34 605 411 213 145
Moderate dyspnoea on exercise 2298 13 300 571 106 202
Severe dyspnoea on exercise 851 5 176 1141 71 460
Respiratory symptom score
1–3 symptoms 6272 36 561 357 228 145
4–6 symptoms 1966 11 244 540 77 170
X7 symptoms 712 4 126 975 47 364
Occupational exposureb
No 13 513 76 1092 318 462 135
Yes 3138 18 357 476 128 170
Smoking habit
Never smoker 6567 37 440 258 265 156
Former smoker 2011 11 192 394 85 175
Current smoker (g tobacco/day) 8838 50 913 423 289 133
o10 2521 14 227 355 86 134
10–19 4399 25 455 422 147 136
X20 1800 10 214 515 50 120
Unknown smoker 262 2 27 434 14 133
a32 persons did not answer any questions about respiratory symptoms.
b1027 persons did not answer this question.
Respiratory symptoms and cardiovascular mortality 2291group was compared with that among persons who had not
reported any respiratory symptoms. The association be-
tween respiratory symptom groups and cardiovascular
mortality was analysed in two different ways. First, this
association was investigated regarding each symptom group
using four separate models. Next, all symptom groups were
included simultaneously as explanatory variables in one
model. The association between symptom score and
mortality were investigated separately. Wald tests for trend
were performed with symptom score and grams of tobacco
smoked as continuous variables.
As the assessment of cause of death based on autopsies
was available from 1986, we investigated the asso-
ciation between respiratory symptoms and mortality of
autopsy-based cause of deaths for the period 1986–2002
separately.The proportional hazard assumption of the Cox model was
checked graphically and with a test based on Schoenfeld’s
residuals.16 Smoking habit and exposure to air pollution
were included as covariates. Separate analyses were
conducted for men and women. At last, we investigated
the association between respiratory symptoms and mortality
in time-periods during follow-up. All analyses were per-
formed with STATA-9.17Results
Of a total of 6710 deaths among respondents, 2881 were
recorded due to cardiovascular disease as the underlying
causes during 1973–2002. IHD accounted for 1572 (55%),
stroke for 653 (23%) and other circulatory diseases for 656
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A. Frostad et al.2292(23%) of all deaths due to circulatory disease. The crude
mortality rate from IHD was higher for men than for women,
while the opposite was found for mortality from stroke
(Table 1).
Generally, persons who reported respiratory symp-
toms had a higher mortality rate than those who
reported no respiratory symptoms. The crude mortality rate
from IHD increased strongly with increasing number of
respiratory symptoms reported, while mortality from stroke
showed a weaker dose–response association. The highest
mortality rate from IHD and stroke was found among persons
who reported severe dyspnoea on exercise (Table 1).
Based on crude figures it is estimated that about 26% of
excess in all cause mortality among those who reported one
or more respiratory symptoms can be explained by excess
in IHD.
The crude mortality rate for IHD among persons exposed
to dust or gases at work was 50% higher than among those
not so exposed and 30% higher for stroke. With respect to
smoking habits, the crude mortality rate for IHD was higher
for smokers than for those who had never smoked and
increased with amount smoked. In contrast, the crude
mortality rate due to stroke was highest for former smokers
and did not differ by amount smoked for current smokers
(Table 1).
When analysing in separate models, the association
between each respiratory symptom group and mortality
from IHD was positive and significant in both sexes (Table 2).
This association appeared to be of similar magnitude
for men and women, except that severe dyspnoea conferred
a higher risk among men than among women. The associa-
tion between respiratory symptoms and mortality was
weaker regarding stroke. A significantly increased risk
was only found among women who reported moderate
dyspnoea and among men who reported severe dyspnoea on
exercise.
The results of the final multivariable model, with all four
symptom groups in one model, are shown in Table 2.
Whereas cough- and asthma-like symptoms were significant
determinants for IHD-mortality using separate models, these
associations decreased toward the null effect when all four
symptom groups were included in one model. For moderate
and severe dyspnoea, however, the association remained
unchanged. However, after adjustment for other respiratory
symptoms, the association between dyspnoea and mortality
from stroke was still significantly positive.
The adjusted association between symptom score and
mortality is shown in Table 3. Mortality from IHD and stroke
increased in a dose–response manner with symptom score,
more strongly for IHD than for stroke. A significant
dose–response association was found between current
smoking and mortality from IHD in men. This association
was of borderline significance among women. No significant
dose–response relation was found between smoking and
mortality from stroke.
Autopsy-confirmed mortality from IHD represented 327
deaths out of totally 1013 IHD-deaths (32%) during the
period 1986–2002, while autopsy-confirmed stroke repre-
sented only 52 of all 482 stroke-deaths (11%) in this period.
After adjustment for age, sex, occupational exposure to air
pollution and smoking habits, the HR for mortality from
autopsy-confirmed IHD were 1.1 (0.8–1.4) for cough, 1.0
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Table 4 Hazard ratio (HR) with 95% confidence interval (CI) for mortality from ischaemic heart disease and stroke by
respiratory symptoms during follow-up, adjusted for age, sex, occupational exposure to air pollution and. smoking habits.
Respiratory symptom Ischaemic heart disease (HR (95% CI)) Stroke (HR (95% CI))
1973–1982
n ¼ 369
1983–1992
n ¼ 658
1993–2002
n ¼ 545
1973–1982
n ¼ 114
1983–1992
n ¼ 252
1993–2002
n ¼ 287
No respiratory
symptoms
1.0 1.0 1.0 1.0 1.0 1.0
Respiratory groups
Cough symptoms 1.5 (1.2–2.0) 1.2 (0.9–1.4) 1.3 (1.0–1.6) 1.3 (0.8–2.1) 1.4 (1.0–1.9) 1.0 (0.7–1.3)
Asthma-like
symptoms
1.5 (1.1–1.9) 1.2 (1.0–1.5) 1.3 (1.1–1.7) 1.5 (0.9–2.3) 1.3 (0.9–1.8) 0.9 (0.7–1.2)
Moderate dyspnoea 2.2 (1.6–3.0) 1.6 (1.2–2.0) 1.6 (1.3–2.1) 1.8 (1.0–3.1) 1.9 (1.3–2.7) 0.8 (0.5–1.3)
Severe dyspnoea 2.8 (1.9–4.1) 2.4 (1.8–3.1) 1.7 (1.1–2.5) 3.1 (1.7–5.5) 0.9 (0.5–1.8) 1.7 (1.0–2.7)
Respiratory symptom
score
1–3 Symptoms 1.4 (1.1–1.8) 1.1 (0.9–1.3) 1.1 (0.9–1.3) 1.3 (0.8–2.1) 1.3 (1.0–1.8) 0.9 (0.7–1.3)
4–6 Symptoms 1.7 (1.2–2.4) 1.5 (1.1–1.9) 1.8 (1.4–2.4) 1.4 (0.7–2.7) 1.4 (0.9–2.1) 1.0 (0.6–1.6)
X7 Symptoms 2.7 (1.7–4.1) 2.2 (1.5–3.1) 1.6 (1.0–2.7) 2.4 (1.2–4.9) 1.4 (0.7–2.9) 1.3 (0.7–2.5)
p-Value, test for
trend
o0.001 o0.001 o0.001 o0.001 0.02 0.4
Separate models for each symptom group.
Table 3 Age-adjusted hazard ratio (HR) with 95% confidence interval (CI) for mortality from ischaemic heart disease and
stroke by respiratory symptom score, occupational exposure and smoking habit, Oslo, Norway, 1973–2002 for each sex.
Ischaemic heart disease (n ¼ 1572) Stroke (n ¼ 653)
Men Women Men Women
HR 95% CI HR 95% CI HR 95% CI HR 95% CI
No respiratory symptom 1.0 1.0 1.0 1.0
Respiratory symptom score
1–3 symptoms 1.2 1.0–1.4 1.1 0.9–1.3 1.0 0.7–1.3 1.2 1.0–1.6
4–6 symptoms 1.6 1.3–2.0 1.7 1.3–2.2 1.7 1.3–2.2 1.2 0.9–1.8
X7 symptoms 2.5 1.9–3.3 1.9 1.5–3.1 2.1 1.5–3.1 1.6 1.0–2.8
p-Value, test for trend o0.0001 o0.0001 0.003 0.03
Occupational exposure
No 1.0 1.0 1.0 1.0
Yes 1.1 0.8–1.3 0.8 0.6–1.0 1.0 0.7–1.3 1.2 0.9–1.6
Smoking habits
Never smoker 1.0 1.0 1.0 1.0
Former smoker 1.1 0.8–1.3 0.8 0.5–1.1 1.0 0.7–1.4 1.0 0.7–1.5
Current smoker (g tobacco/day)
po10 1.5 1.2–1.9 1.5 1.2–1.9 1.6 1.1–2.5 0.9 0.6–1.3
10–19 1.6 1.3–2.0 2.0 1.6–2.5 1.2 0.8–1.8 1.5 1.1–2.0
X20 1.8 1.4–2.3 1.8 1.2–2.8 1.0 0.6–1.7 1.6 1.0–2.8
p-Value, test for trend 0.005 0.07 0.8 0.09
Simultaneous analysis of all respiratory symptoms.
Respiratory symptoms and cardiovascular mortality 2293(0.8–1.4) for asthma-like symptoms, 1.3 (0.9–1.8) for
moderate dyspnoea and 1.6 (0.9–2.6) for severe dyspnoea.
Similarly, the adjusted HR for mortality from autopsy-
confirmed stroke was 1.8, 1.1, 1.1 and 1.5 regarding coughsymptoms, asthma-like symptoms, moderate and severe
dyspnoea, respectively, but none were significant.
The adjusted HR for IHD-mortality decreased for all
respiratory symptoms groups during follow-up, but was still
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Table 5 Hazard ratio (HR) with 95% confidence interval (CI) for mortality from ischaemic heart disease and stroke by
respiratory symptoms, adjusted for smoking habit, occupational exposure to air pollution and age, Oslo, Norway, 1973–2002
for each sex.
Respiratory symptom Ischaemic heart disease (n ¼ 1274) Stroke (n ¼ 578)
Men Women Men Women
HR 95% CI HR 95% CI HR 95% CI HR 95% CI
No respiratory symptoms 1.0 1.0 1.0 1.0
Cough symptoms 1.2 1.0–1.5 1.1 0.9–1.4 1.0 0.7–1.4 1.2 0.9–1.6
Asthma-like symptoms 1.2 1.0–1.5 1.2 0.9–1.4 1.0 0.8–1.5 1.0 0.7–1.3
Moderate dyspnoea 1.5 1.2–2.0 1.4 1.1–1.8 1.2 0.8–1.9 1.4 1.0–2.0
Severe dyspnoea 2.3 1.6–3.3 1.6 1.1–2.2 1.7 0.9–3.1 1.4 0.9–2.3
Individuals with self-reported diagnosed heart diseasesa excluded. Separate models for each symptom group.
aAngina pectoris, myocardial infarction, heart failure and other heart diseases.
A. Frostad et al.2294significantly increased in the third decade, except among
persons reporting less than four respiratory symptoms
(Table 4). The HR for mortality from stroke also decreased
considerably during follow-up. The positive association
between symptom score and mortality from stroke was less
present the last decade of follow-up.
Among those 957 persons who at baseline reported
physician-diagnosed angina pectoris, myocardial infarction,
heart failure or other heart diseases, 298 were dead in IHD
and 75 dead in stroke. After exclusion of these 957 persons
the association between most of the respiratory symptoms
and mortality from IHD and stroke was still positive for both
men and women (Table 5).Discussion
In this cohort of nearly 18 000 men and women, we found a
higher risk for death from IHD and stroke over 30 years
among subjects who reported respiratory symptoms than
among those reporting no respiratory symptoms. The risk
increased with the number of symptoms reported at base-
line. The relative risk of respiratory symptoms regarding
mortality from IHD and stroke decreased slightly during
follow-up but was still increased after 20 years with regard
to IHD-mortality.
The strength of this population-based study is the large
number of respondents, the long follow-up that resulted in
over 400 000 person–years and the large number of deaths.
To our knowledge, no other population-based study has
included analysis of so many respiratory symptoms as
predictors of mortality from IHD and stroke. The partici-
pants answered the questionnaire at home, thus reducing
observer bias. Because of the availability of the unique
11-digit personal identification number used in Norway and
because Statistics Norway, by law, records all deaths in the
country, the estimates are not distorted by incomplete
follow up.18
The main source of uncertainty with regard to cause
of death is physicians’ reporting of diagnoses on death
certificates.19 Uncertainty about the cause of death can
lead to non-differential misclassification, thus biasing
the association between respiratory symptoms and mortalitytowards a null effect.20 The gold standard for deter-
mining cause of death is however, the autopsy,
and the analysis in our study based on autopsy-recor-
ded causes of death gave similar results with over-
lapping confidence intervals to those obtained from death
certificates.
Smoking is a potential confounder of the association
between respiratory symptoms and death. Although we
controlled for smoking habits before inclusion, the pre-
valence of smoking in our cohort might have changed during
follow-up. Stavem et al.21, however, reported that 32% of a
cohort of middle-aged men followed for 27 years had
stopped smoking and only 16% had started smoking or
started smoking again. Eagan et al. 22 found in a population
cohort, aged 15–70 years, followed from 1985 to 1996 that
12% of men and 10% of women stopped smoking, while only
5% men and women started smoking over a follow-up period
of 11 years. As the total proportion of daily smokers among
Norwegian men and women decreased during the follow-up
period,23 some of the respondents in our study might have
stopped smoking in response to the Norwegian Tobacco Act
and to educational programmes on smoking and health.24 A
considerable proportion of the persons who smoked and
reported symptoms might have had fewer symptoms after
quitting25. However, we are not able in our analyses to take
into account the changes in respiratory symptoms during the
follow-up time.
According to reporting of respiratory symptoms, Eagan
et al. found that the remission rate for a 11-year span in
time varied from 45% for dyspnoea to 58% for chronic
cough.25 Our study design does not allow verifying the
possible lack of persistence of respiratory symptoms.
Despite this individual variation of respiratory symptoms,
we have found a strong association between symptoms
reported at one time in 1972 and mortality of IHD for the
following 30 years.
Furthermore our study has no information about socio-
economic position, physical activity, diet or other cardio-
vascular risk factors. Although the lack of this information
could be a weakness of our study, Stavem et al. showed in an
occupational cohort of middle-age men followed for 26
years that phlegm and breathlessness were associated with
all cause mortality, even after adjustment for physical
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Respiratory symptoms and cardiovascular mortality 2295fitness and lung function as well as known cardiovascular
disease and smoking. This association was not significant
regarding cardiovascular mortality as this cohort included
only included 1999 men.26 Additionally, Juosilahti et al.
found in a study of nearly 20 000 Finnish men and women
followed for 13 years that symptoms of chronic bronchitis
(i.e. cough with phlegm 3 months or more during a year)
predicted risk of cardiovascular death independently from
other known major cardiovascular risk factors.27
In the present study, each respiratory symptom group and
symptom score was significantly associated with increased
mortality from IHD. Our findings are partly in agreement
with those of smaller population-based studies.28–31 Todd
et al. found a positive association between chronic cough
and IHD-mortality in both sexes.28 Knuiman et al., however,
found this association significant only in men.31 Two studies
showed increased risk of IHD-mortality when reporting
moderate dyspnoea.30,31
In relation to asthma-like symptoms, two studies
showed that persons with asthma or symptoms of asthma
had, as in our study, a higher risk of 20–40% for death
from cardiovascular disease than those without asthma
symptoms.29,32
However, when adjusting for dyspnoea, no risk of IHD-
mortality due to cough and asthma-like symptoms were
observed. IHD may be closer associated with inflammatory
processes in the peripheral airways causing airflow obstruc-
tions and thus dyspnoea than with inflammatory processes
in the central airways causing cough and asthma-like
symptoms.
Dyspnoea can also be due to non-respiratory diseases and
non-cardiovascular diseases. However, an exclusion of those
individuals who reported physician diagnosed heart dis-
eases, the mortality risk for IHD and stroke were still
increased.
With regard to mortality from stroke, we found a positive
association with most of the respiratory symptoms and
mortality. Todd et al. and Knuiman et al., however, showed a
not significant negative association between chronic cough
and mortality from stroke in both sexes.28,31 Our significant
increased risk for mortality from stroke among persons who
reported dyspnoea confirms the results of men in the study
of Rosengren et al.30 We have no explanation for the finding
that asthma-like symptoms may be protective against stroke
in women but not in men, this should be further examined in
future population-based studies.
Respiratory symptoms are major characteristics of in-
flammatory processes in the lungs, and inflammation plays a
role in the pathogenesis of atherothrombosis.33,34 Our study
does not elucidate the mechanisms by which respiratory
symptoms cause earlier death or why a single self-report of
symptoms has such a long-lasting effect on mortality rates.
We have nevertheless shown that common respiratory
symptoms are important predictors of mortality from
cardiovascular disease over a period of 30 years. Recording
of symptoms is simple, cheap and applicable to most people.
Awareness of even common respiratory symptoms is im-
portant for detecting underlying disease. Our observational
study may give support to the earlier hypothesis that
modulating pulmonary inflammation may favourably alter
a cardiovascular outcome.3 This has, however, to be
confirmed in controlled clinical trials.Conflict of interest statement
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Appendix A. Respiratory symptoms and
questions used to define themQuestion in 1972 questionnaire Respiratory
symptom in our
study8 Do you usually cough and clear
your throat in the morning?Cough symptoms9 Do you usually cough during the
day?10 When you cough or clear your
throat, do you usually bring up
phlegm?11 Do you have cough for 3 months or
more altogether during a year?12 During the past 2 years, have you
had a cough and/or phlegm in
connection with a cold for more
than 3 weeks?Asthma-like
symptoms17 Do you have attacks of
breathlessness?18 Have you ever had wheezing in
your chest?13 Are you more breathless than
people of your own age when
walking uphill?Moderate dyspnoea14 Are you breathless when you climb
two flights of stairs at an ordinary
pace?15 Are you breathless when you walk
on level ground at an ordinary
pace?Severe dyspnoea16 Are you breathless when at rest?References
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